Two Sigma Investments’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-5,167
| Closed | -$66.2K | – | 2951 |
|
2023
Q4 | $66.2K | Buy |
+5,167
| New | +$66.2K | ﹤0.01% | 2885 |
|
2023
Q3 | – | Sell |
-610
| Closed | -$24.6K | – | 2871 |
|
2023
Q2 | $24.6K | Buy |
+610
| New | +$24.6K | ﹤0.01% | 2812 |
|
2023
Q1 | – | Sell |
-3,705
| Closed | -$304K | – | 2881 |
|
2022
Q4 | $304K | Buy |
3,705
+3,232
| +683% | +$265K | ﹤0.01% | 2180 |
|
2022
Q3 | $45K | Buy |
+473
| New | +$45K | ﹤0.01% | 2276 |
|
2021
Q4 | – | Sell |
-9,845
| Closed | -$4.41M | – | 2576 |
|
2021
Q3 | $4.41M | Sell |
9,845
-9,493
| -49% | -$4.25M | 0.01% | 973 |
|
2021
Q2 | $7.52M | Sell |
19,338
-18,890
| -49% | -$7.34M | 0.02% | 757 |
|
2021
Q1 | $13.7M | Sell |
38,228
-1,592
| -4% | -$572K | 0.04% | 483 |
|
2020
Q4 | $19.5M | Buy |
39,820
+18,545
| +87% | +$9.1M | 0.06% | 341 |
|
2020
Q3 | $6.89M | Buy |
21,275
+16,529
| +348% | +$5.36M | 0.02% | 520 |
|
2020
Q2 | $1.73M | Buy |
4,746
+1,506
| +46% | +$549K | 0.01% | 931 |
|
2020
Q1 | $689K | Sell |
3,240
-6,385
| -66% | -$1.36M | 0.01% | 1129 |
|
2019
Q4 | $3.96M | Buy |
9,625
+5,912
| +159% | +$2.43M | 0.01% | 828 |
|
2019
Q3 | $1.31M | Buy |
+3,713
| New | +$1.31M | ﹤0.01% | 1088 |
|
2015
Q3 | – | Sell |
-619
| Closed | -$816K | – | 1648 |
|
2015
Q2 | $816K | Buy |
+619
| New | +$816K | ﹤0.01% | 1512 |
|